Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S18 pseudogene 6 (RPS18P6) is a processed pseudogene in the mouse genome. It is a non-functional copy of the ribosomal protein S18 gene, which is a component of the small 40S ribosomal subunit responsible for catalyzing protein synthesis in cells. Unlike the canonical RPS18 gene, RPS18P6 lacks coding potential and does not encode a functional protein. It does not have established biological function, disease associations, or roles as a therapeutic target[7][8]. In summary, RPS18P6 is a non-functional pseudogene and thus should not be considered a therapeutic target, biomarker, or drug-interaction partner. If referenced as a target, this is likely due to incorrect annotation or confusion with the functional RPS18 gene[7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S18 pseudogene 6 (RPS18P6).